← All startups

BeOne Medicines

BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.

Cambridge, MA, United States34 people
Biotechnology

Team34

NameLocationLinksContact
John V. Oyler
Founder
—
—
Julie Lepin
SVP Chief Regulatory Affairs Officer
—
—
Małgorzata Poznańska
Senior Manager
—
—
Marcello Damiani
Chief Technology Officer
—
—
Xiaobin Wu
Global President
—
—
Xiaodong Wang
Chairman of Scientific Advisory Board Co-Founder
—
—
Anne Munsell Webster
Vice President
—
—
Kyu-Sung Lee
Senior Vice President
—
—
Minhong Yan
Vp
—
—
Alessandro Riva
Director
—
—
Anand Reddi
VP
—
—
Anthony Hooper
Director
—
—
Erhan Berber
Executive Director
—
—
Gloria Lai
Senior Director
—
—
Guiyu Jin
Senior HR Director
—
—
Jennifer Morse
Associate Director
—
—
Jenny Krenz
Director Compensation
—
—
Jill Heist
HRBP Global Enabling Functions
—
—
Kellie Woodworth
Director
—
—
Margaret Dugan
Director
—
—
Michael Goller
Director
—
—
Michael Nuoqing Yi
Director
—
—
Olivier Brandicourt
Director
—
—
Philip Watson Mb Msc Frcp Ffpm
Executive Director
—
—
Ranjeev Krishana
Director
—
—
Senthil Sockalingam
Executive Medical Director
—
—
Shalini Sharp
Director
—
—
Shaohui Wang
Senior Director
—
—
Vasantha Malladi
Senior Director
—
—
Danielle MacIag
HR Operations Manager
—
—
Charles Sawyers
Advisor
—
—
David Schenkein
Advisor
—
—
Neal Rosen
Advisor
—
—
Steven Young
Advisor
—
—
Join Discord